GeneDx Holdings Corp. (WGS) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $5.15M; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value $26.83M; Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $5.15M | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $5.15M |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | $26.83M | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Reported amount: $26.83M |
| Other obligations · due after 1 year (USD) | (m) | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 237.26M USD | Liabilities |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Amounts owed to suppliers | 5.15M USD | Accounts Payable, Current |
| Total deferred revenue | (m) | Contract with Customer, Liability · Contract with Customer, Liability, Current · Deferred Revenue, Noncurrent |
| Deferred revenue due within one year | (m) | Contract with Customer, Liability, Current |
| Deferred revenue due after one year | (m) | Deferred Revenue, Noncurrent · Contract with Customer, Liability · Contract with Customer, Liability, Current |
| Reported other obligations due within one year | 26.83M USD | Other Liabilities, Current |
| Reported other noncurrent obligations | 71.00K USD | Other Liabilities, Noncurrent |
| Deferred revenue included in other noncurrent obligations | (m) | Contract with Customer, Liability · Contract with Customer, Liability, Current |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- $26.83M
- Other obligations · due after 1 year (USD)
- (m)
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Obligation categories | (m) |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $5.15M | (m) | $26.83M | (m) | $237.26M | (m) | (m) | (m) | $71.00K | (m) |
| 2026-03-31 | (m) | $11.17M | (m) | $35.95M | (m) | $252.18M | (m) | (m) | (m) | $71.00K | (m) |
| 2025-12-31 | (m) | $2.46M | (m) | $46.86M | (m) | $215.53M | (m) | (m) | (m) | $1.64M | (m) |
| 2025-09-30 | (m) | $2.63M | (m) | $32.86M | (m) | $201.64M | (m) | (m) | (m) | $4.26M | (m) |
| 2025-06-30 | (m) | $3.52M | (m) | $19.08M | (m) | $186.73M | (m) | (m) | (m) | $3.27M | (m) |
| 2025-03-31 | (m) | $15.86M | (m) | $24.55M | (m) | $189.03M | (m) | (m) | (m) | $6.62M | (m) |
| 2024-12-31 | (m) | $7.95M | (m) | (m) | (m) | $174.13M | (m) | (m) | (m) | $5.52M | (m) |
| 2024-09-30 | (m) | $9.02M | (m) | (m) | (m) | $204.34M | (m) | (m) | (m) | $13.54M | (m) |
| 2024-06-30 | (m) | $8.13M | (m) | (m) | (m) | $195.06M | (m) | (m) | (m) | $12.66M | (m) |
| 2024-03-31 | (m) | $9.48M | (m) | (m) | (m) | $187.31M | (m) | (m) | (m) | $20.84M | (m) |
| 2023-12-31 | (m) | $10.24M | (m) | (m) | (m) | $190.74M | (m) | (m) | (m) | $14.73M | (m) |
| 2023-09-30 | (m) | $15.37M | (m) | (m) | (m) | $163.03M | (m) | (m) | (m) | $22.66M | (m) |
| 2023-06-30 | (m) | $25.01M | (m) | (m) | (m) | $180.28M | (m) | (m) | (m) | $22.41M | (m) |
| 2023-03-31 | (m) | $36.92M | (m) | $39.63M | (m) | $216.83M | (m) | (m) | (m) | $22.11M | (m) |
| 2022-12-31 | (m) | $46.02M | (m) | $49.66M | (m) | $237.24M | (m) | $40.00K | (m) | $22.00M | (m) |
| 2022-09-30 | (m) | $40.12M | $2.82M | $68.62M | $17.38M | $267.68M | (m) | $0.00 | $2.82M | $20.20M | $2.82M |
| 2022-06-30 | (m) | $53.30M | $3.17M | $81.62M | $-2.67M | $296.01M | (m) | $0.00 | $3.17M | $500.00K | $3.17M |
| 2022-03-31 | (m) | (m) | $3.81M | $23.38M | $-3.25M | $188.23M | (m) | $66.00K | $3.75M | $500.00K | $3.75M |
| 2021-12-31 | (m) | $44.69M | $3.77M | $29.97M | $184.00K | $165.99M | (m) | $473.00K | $3.30M | $3.48M | $3.30M |
| 2021-09-30 | (m) | (m) | $3.46M | (m) | $18.73M | $212.09M | (m) | $493.00K | $2.96M | $21.70M | $2.96M |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | $130.42M | (m) | (m) | $15.50M | (m) | $0.00 |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | $143.95M | (m) | (m) | $15.50M | (m) | $0.00 |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | $15.59M | (m) | (m) | $15.50M | (m) | $0.00 |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | $15.54M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |